🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Extensive research employing diverse omics methodologies has unveiled a var...
Status
Completed
Location
Fujian Medical University Union Hospital
Start Date
2022-06-01
Trial ID
NCT06376773
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
This is a single arm, open-label, non-randomized and single-center phase II...
Status
Unknown
Location
Li Xu
Start Date
2020-08-01
Trial ID
NCT04454905
Treatments Being Tested
This an open-label，Non-Randominzed Phase 2 study to evaluate the Safety and...
Status
Completed
Location
The Second Affiliated Hospital Of Anhui Medical University
Start Date
2017-04-24
Trial ID
NCT03092895
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This is an open-label, single center, non-randomized, phase Ⅱ trial to eval...
Status
Unknown
Location
Zhejiang Province Cancer Hospital
Start Date
2020-07-01
Trial ID
NCT04446091
This single arm, open label, single center, prospective study was designed ...
Status
Unknown
Location
Beijing Union Medical College Hospital
Start Date
2020-06-08
Trial ID
NCT04453930
Treatments Being Tested
This study is a single arm, open label, national multicenter study, to expl...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2020-08-26
Trial ID
NCT04459078
Treatments Being Tested
This study used (cTACE or DEB-TACE + FOLFOX scheme HAIC) combined with PD-1...
Status
Unknown
Location
Multiple Locations
Start Date
2021-04
Trial ID
NCT04479527
Treatments Being Tested
SHR-1210 is a humanized anti-PD1 IgG4 monoclonal antibody. This is an openl...
Status
Unknown
Location
Department of Radiation Oncology, Tianjin Medical University Cancer Hospital
Start Date
2018-09-17
Trial ID
NCT03671265
Treatments Being Tested